Clinical Trial Update: Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) [Phase 3]

View source ↗

Summary

Phase 3 trial update on mesalamine 2 g sachet for maintaining remission in ulcerative colitis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• mesalamine 2 g sachet (mesalamine)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2021-09-14